Gilead Sciences (GILD) FCF Margin Growth (3y) (2012 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Margin Growth (3y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
- |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
-7.00 |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
-537.00 |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
-911.00 |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
1,568.00 |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
534.00 |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
913.00 |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
9,115.00 |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
-1,716.00 |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
913.00 |
| Dec 31, 2025 |
710.00 |
| Sep 30, 2025 |
1,256.00 |
| Jun 30, 2025 |
-1,633.00 |
| Mar 31, 2025 |
62.00 |
| Dec 31, 2024 |
-473.00 |
| Sep 30, 2024 |
1,328.00 |
| Jun 30, 2024 |
-1,815.00 |
| Mar 31, 2024 |
-645.00 |
| Dec 31, 2023 |
409.00 |
| Sep 30, 2023 |
-869.00 |
| Jun 30, 2023 |
-1,379.00 |
| Mar 31, 2023 |
294.00 |
| Dec 31, 2022 |
-814.00 |
| Sep 30, 2022 |
-520.00 |
| Jun 30, 2022 |
-1,144.00 |
| Mar 31, 2022 |
-120.00 |
| Dec 31, 2021 |
590.00 |
| Sep 30, 2021 |
542.00 |
| Jun 30, 2021 |
1,275.00 |
| Mar 31, 2021 |
-238.00 |
| Dec 31, 2020 |
-1,920.00 |
| Sep 30, 2020 |
-754.00 |
| Jun 30, 2020 |
-54.00 |
| Mar 31, 2020 |
-2,035.00 |
| Dec 31, 2019 |
-561.00 |
| Sep 30, 2019 |
-1,230.00 |
| Jun 30, 2019 |
-2,354.00 |
| Mar 31, 2019 |
-2,534.00 |
| Dec 31, 2018 |
-2,999.00 |
| Sep 30, 2018 |
-939.00 |
| Jun 30, 2018 |
-4,397.00 |
| Mar 31, 2018 |
-3,299.00 |
| Dec 31, 2017 |
356.00 |
| Sep 30, 2017 |
-2,531.00 |
| Jun 30, 2017 |
-1,499.00 |
| Mar 31, 2017 |
1,507.00 |
| Dec 31, 2016 |
2,495.00 |
| Sep 30, 2016 |
3,021.00 |
| Jun 30, 2016 |
2,868.00 |
| Mar 31, 2016 |
2,571.00 |
| Dec 31, 2015 |
4,932.00 |
| Sep 30, 2015 |
1,796.00 |
| Jun 30, 2015 |
1,445.00 |
| Mar 31, 2015 |
5,461.00 |
| Dec 31, 2014 |
-424.00 |
| Sep 30, 2014 |
2,544.00 |
| Jun 30, 2014 |
1,976.00 |
| Mar 31, 2014 |
-1,374.00 |
| Dec 31, 2013 |
-1,400.00 |
| Sep 30, 2013 |
-1,188.00 |
| Jun 30, 2013 |
-264.00 |
| Mar 31, 2013 |
-658.00 |
| Dec 31, 2012 |
-2,882.00 |
| Sep 30, 2012 |
-1,879.00 |
| Jun 30, 2012 |
1,556.00 |
| Mar 31, 2012 |
-1,235.00 |
